Modification of Introduction Requirements for Resubmissions to PAR-10-096, Investigator-initiated Multi-site Clinical Trials (Collaborative R01)

Notice Number: NOT-HL-11-146

Key Dates
Release Date: June 3, 2011

Issued by
National Heart, Lung, and Blood Institute (NHLBI), (http://www.nhlbi.nih.gov)

Purpose

On January 27, 2010, the NHLBI issued a Funding Opportunity Announcements (FOA): “Investigator Initiated Multi-Site Clinical Trials (Collaborative R01)”, https://grants.nih.gov/grants/guide/pa-files/PAR-10-096.html.

The following corrections to this FOA are being made:


Section III. Eligibility Information

3. Other-Special Eligibility Criteria

Renewals.

OLD LANGUAGE:
The Introduction and response to reviewer’s critiques should be integrated such that an identical Introduction is provided for each application that is part of a cluster.

NEW LANGUAGE:
Each application that is a part of a cluster may provide a separate introduction and response to reviewer's critiques pertinent to that application.


All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Dr. Keary Cope
NHLBI Division of Extramural Research Activities
6701 Rockledge Drive
Rockledge 2, Room 7190
Telephone: (301) 435-0287
Fax: (301) 451-5425
Email: copeka@nhlbi.nih.gov